BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7497445)

  • 21. [Immunophenotypic features of acute myeloid leukemia with AML-1/ETO fusion gene].
    Zhang JJ; DU X; Huang ZX; Su JH; Zhou MH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):378-81. PubMed ID: 17493351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic importance of cytogenetic subgroups in de novo pediatric acute nonlymphocytic leukemia.
    Kalwinsky DK; Raimondi SC; Schell MJ; Mirro J; Santana VM; Behm F; Dahl GV; Williams D
    J Clin Oncol; 1990 Jan; 8(1):75-83. PubMed ID: 2295913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Immunophenotypic and clinical characteristic analysis of NPM1 mutated acute myeloid leukemia with a normal karyotype].
    Liu YR; Lai YY; Chang Y; Ruan GR; Qin YZ; Wang YZ; Zhu HH; Shi HX; Jiang B; Jiang H; Jiang Q; Hao L; Li JL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1385-9. PubMed ID: 24370016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinctive immunophenotypic features of t(8;21)(q22;q22) acute myeloblastic leukemia in children.
    Hurwitz CA; Raimondi SC; Head D; Krance R; Mirro J; Kalwinsky DK; Ayers GD; Behm FG
    Blood; 1992 Dec; 80(12):3182-8. PubMed ID: 1467524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute myeloid leukemia: correlation between purine metabolism enzyme activities and membrane immunophenotype.
    Mesárosová A; Hrivnáková A; Babusíková O
    Neoplasma; 1993; 40(6):341-5. PubMed ID: 8289964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A correlation study of immunophenotypic, cytogenetic, and clinical features of 180 AML patients in China.
    Zheng J; Wang X; Hu Y; Yang J; Liu J; He Y; Gong Q; Yao J; Li X; Du W; Huang S
    Cytometry B Clin Cytom; 2008 Jan; 74(1):25-9. PubMed ID: 18061959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute myeloid leukemia with MLL rearrangements: clinicobiological features, prognostic impact and value of flow cytometry in the detection of residual leukemic cells.
    Muñoz L; Nomdedéu JF; Villamor N; Guardia R; Colomer D; Ribera JM; Torres JP; Berlanga JJ; Fernández C; Llorente A; Queipo de Llano MP; Sánchez JM; Brunet S; Sierra J;
    Leukemia; 2003 Jan; 17(1):76-82. PubMed ID: 12529663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cytogenetic abnormality and prognosis in childhood acute myeloblastic leukemia. Children's Cancer and Leukemia Study Group (CCLSG)].
    Katano N; Tsurusawa M; Hirota T; Horikoshi Y; Mimaya J; Iwai T; Kaneko Y; Tsuji Y; Fujimoto T
    Rinsho Ketsueki; 1997 Aug; 38(8):647-56. PubMed ID: 9311270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of the C-kit receptor (CD117) is a feature of almost all subtypes of de novo acute myeloblastic leukemia (AML), including cytogenetically good-risk AML, and lacks prognostic significance.
    Schwartz S; Heinecke A; Zimmermann M; Creutzig U; Schoch C; Harbott J; Fonatsch C; Löffler H; Büchner T; Ludwig WD; Thiel E
    Leuk Lymphoma; 1999 Jun; 34(1-2):85-94. PubMed ID: 10350335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of cell marker analysis in de novo acute myeloid leukemia.
    Del Poeta G; Stasi R; Venditti A; Suppo G; Aronica G; Bruno A; Masi M; Tabilio A; Papa G
    Leukemia; 1994 Mar; 8(3):388-94. PubMed ID: 7907393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunophenotype of acute myeloid leukemia with NPM mutations: prognostic impact of the leukemic compartment size.
    Nomdedeu J; Bussaglia E; Villamor N; Martinez C; Esteve J; Tormo M; Estivill C; Queipo MP; Guardia R; Carricondo M; Hoyos M; Llorente A; Juncà J; Gallart M; Domingo A; Bargay J; Mascaró M; Moraleda JM; Florensa L; Ribera JM; Gallardo D; Brunet S; Aventin A; Sierra J;
    Leuk Res; 2011 Feb; 35(2):163-8. PubMed ID: 20542566
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD56 expression in myeloperoxidase-negative FAB M5 acute myeloid leukemia.
    Delgado J; Morado M; Jimenez MC; Garcia-Grande A; Hernandez-Navarro F
    Am J Hematol; 2002 Jan; 69(1):28-30. PubMed ID: 11835327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical, morphologic, cytogenetic and prognostic implications of CD34 expression in childhood and adult de novo AML.
    Sperling C; Büchner T; Creutzig U; Ritter J; Harbott J; Fonatsch C; Sauerland C; Mielcarek M; Maschmeyer G; Löffler H
    Leuk Lymphoma; 1995 May; 17(5-6):417-26. PubMed ID: 7549832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD117 (c-kit) is a restricted antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtype.
    Cascavilla N; Musto P; D'Arena G; Melillo L; Carella AM; Petrilli MP; Sanpaolo G; Carotenuto M
    Haematologica; 1998 May; 83(5):392-7. PubMed ID: 9658721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and hematological correlates of aberrant immunophenotypic profiles in adult and pediatric acute myeloid leukemia at presentation.
    Sharma M; Varma N; Singh Sachdeva MU; Bose P; Varma S
    J Cancer Res Ther; 2020; 16(1):105-109. PubMed ID: 32362618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunophenotypic patterns and cytogenetic anomalies in acute non-lymphoblastic leukemia subtypes: a prospective study of 432 patients.
    Casasnovas RO; Campos L; Mugneret F; Charrin C; Béné MC; Garand R; Favre M; Sartiaux C; Chaumarel I; Bernier M; Faure G; Solary E
    Leukemia; 1998 Jan; 12(1):34-43. PubMed ID: 9436918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phenotypical characteristics of acute myelocytic leukemia associated with the t(8;21)(q22;q22) chromosomal abnormality: frequent expression of immature B-cell antigen CD19 together with stem cell antigen CD34.
    Kita K; Nakase K; Miwa H; Masuya M; Nishii K; Morita N; Takakura N; Otsuji A; Shirakawa S; Ueda T
    Blood; 1992 Jul; 80(2):470-7. PubMed ID: 1378322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunological classification of acute myeloblastic leukemias: relevance to patient outcome.
    Casasnovas RO; Slimane FK; Garand R; Faure GC; Campos L; Deneys V; Bernier M; Falkenrodt A; Lecalvez G; Maynadié M; Béné MC
    Leukemia; 2003 Mar; 17(3):515-27. PubMed ID: 12646939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunophenotypic features of acute myeloid leukemia with inv(3)(q21q26.2)/t(3;3)(q21;q26.2).
    Medeiros BC; Kohrt HE; Arber DA; Bangs CD; Cherry AM; Majeti R; Kogel KE; Azar CA; Patel S; Alizadeh AA
    Leuk Res; 2010 May; 34(5):594-7. PubMed ID: 19781775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytogenetic study of acute lymphoblastic leukemia and its correlation with immunophenotype and genotype.
    Tien HF; Wang CH; Lee FY; Liu MC; Chuang SM; Chen YC; Shen MC; Lin DT; Lin KH; Chuu WM
    Cancer Genet Cytogenet; 1992 Apr; 59(2):191-8. PubMed ID: 1581884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.